Pubblicazioni

CML-466 Asciminib Provides Durable Molecular Responses in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With the T315I Mutation: Updated Efficacy and Safety Data From a Phase I Trial

2022 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Hughes, Timothy P.; Cortes, Jorge E.; RÃ©a, Delphine; Mauro, Michael J.; Hochhaus, Andreas; Kim, Dong-Wook; Sasaki, Koji; Lang, Fabian; Heinrich, Michael C.; Breccia, Massimo; Deininger, Michael; Goh, Yeow-Tee; Janssen, Jeroen J. W. M; Talpaz, Moshe; Coutre, Philipp le; Kapoor, Shruti; Cacciatore, Silvia; Polydoros, Fotis; Agrawal, Nithya; Mahon, Francois-Xavier